Related Experiment Videos
C-peptide in juvenile diabetes
Insights
Juvenile diabetes patients often retain significant insulin production, indicated by C-peptide levels, even during ketoacidosis. Early intervention may preserve crucial beta cell function, improving metabolic stability.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Research
Background:
- C-peptide is a reliable marker for endogenous insulin secretion, particularly in insulin-treated diabetic patients with insulin antibodies.
- Juvenile diabetes onset is often associated with minimal insulin production, but this study observed higher C-peptide levels than anticipated, even in ketoacidotic states.
Purpose of the Study:
- To investigate the presence and significance of endogenous insulin secretion, measured by C-peptide levels, in juvenile diabetes patients.
- To explore the relationship between C-peptide levels, metabolic stability, and the progression of beta cell failure in juvenile diabetes.
- To assess the potential impact of early detection and intensive treatment on preserving beta cell function.
Main Methods:
- Measurement of C-peptide levels in juvenile diabetes patients at various stages, including onset, ketoacidosis, and remission periods.
- Monitoring metabolic stability and insulin secretion capacity over time.
- Correlation analysis between C-peptide levels, metabolic control, and disease progression.
Main Results:
- Elevated C-peptide levels were observed even in ketoacidotic juvenile diabetes patients, indicating that ketoacidosis does not signify irreversible beta cell failure.
- Many patients exhibit normal or near-normal C-peptide levels during the post-initial remission period, with responsive beta cells.
- Persistent beta cell function, even in trace amounts, was found to be important for metabolic stabilization, and its preservation may be enhanced by early, intensive treatment.
Conclusions:
- Beta cell failure in juvenile diabetes is not necessarily predetermined and may be influenced by treatment strategies.
- Early detection and intensive management of diabetes before severe metabolic disturbances can potentially preserve residual beta cell function.
- Maintaining some level of beta cell function is critical for long-term metabolic control in juvenile diabetes.
Abstract:
C-peptide can be used as a measure of endogenous insulin secretion in insulin treated diabetics with insulin antibodies. At the onset of juvenile diabetes insulin production is thought to be absent or minimal, but we have found rather high levels of C-peptide, even in ketoacidotic patients. The ketoacidosis does not mean an irreversible beta cell failure. In the postinitial remission period with stable metabolism many patients have normal or almost normal C-peptide levels and their beta cells have the capacity to respond to natural stimulation with an increased insulin secretion. For some unknown reason the metabolism becomes more labile coinciding with decreasing C-peptide values. However, even several years beyond the postinitial remission period many juvenile diabetics have some persistent beta cell function, and it has been shown that even trace remnants of beta cell function are of importance for stabilization of the metabolism. There is no reason to believe that the beta cell failure should be predetermined e.g. by genetic factors. However, little is known how to influence the progression and stop the increasing beta cell failure. Some of our results suggest that an early detection and an intensive treatment of diabetes before severe metabolic disturbances and pronounced insulin deficiency have appeared, may increase the possibility of preserving some beta cell function.